Literature DB >> 12241630

Painful ulcers in calciphylaxis - combined treatment with maggot therapy and oral pentoxyfillin.

J Tittelbach1, T Graefe, U Wollina.   

Abstract

BACKGROUND: Calciphylaxis is a rare syndrome developing predominantly in female patients suffering from end-stage renal disease (ESRD) with secondary hyperparathyroidism. Skin lesions begin as superficial patches that quickly progress to painful necrotic ulcers. Histopathological findings are calcification of small arteries and arterioles and infarction of subcutis and skin. The prognosis of calciphylaxis is poor due to an increased risk of systemic infection.
METHODS: We report on a 50-year-old woman suffering from calciphylaxis. Initial treatments were not tolerated due to pain and therefore the patient was treated with maggot therapy and 800 mg/day of oral pentoxyfillin.
RESULTS: Over a period of 6 months a complete remission of her skin lesions was achieved.
CONCLUSION: Patients suffering from ulcers due to calciphylaxis may benefit from the use of maggot therapy, which cleanses ulcers and prevents systemic infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12241630     DOI: 10.1080/09546630152696035

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  11 in total

1.  [Calciphylaxis. Pathogenesis and therapy].

Authors:  N-P Hoff; B Homey
Journal:  Hautarzt       Date:  2011-07       Impact factor: 0.751

Review 2.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

Review 3.  [Cutaneous calciphylaxis].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

4.  Pentoxifylline treatment and penile calcifications in men with Peyronie's disease.

Authors:  James F Smith; Alan W Shindel; Yun-Ching Huang; Raul I Clavijo; Lawrence Flechner; Benjamin N Breyer; Michael L Eisenberg; Tom F Lue
Journal:  Asian J Androl       Date:  2010-11-22       Impact factor: 3.285

5.  Atypical presentation of purpura fulminans following sepsis in an adult.

Authors:  Paul Lyon; Rabi Nambi; Faisal Faruqi
Journal:  BMJ Case Rep       Date:  2011-10-28

Review 6.  Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management.

Authors:  Preethi Yerram; Kunal Chaudhary
Journal:  Ochsner J       Date:  2014

7.  Treatment of severe metastatic calcification and calciphylaxis in dialysis patients.

Authors:  Saurabh K Goel; Keith Bellovich; Peter A McCullough
Journal:  Int J Nephrol       Date:  2011-02-24

8.  Update on cutaneous calciphylaxis.

Authors:  Uwe Wollina
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

9.  Calciphylaxis in chronic, non-dialysis-dependent renal disease.

Authors:  Rainer U Pliquett; Jörg Schwock; Ralf Paschke; Harald Achenbach
Journal:  BMC Nephrol       Date:  2003-09-29       Impact factor: 2.388

10.  Maggot therapy for calciphylaxis wound debridement complicated by bleeding.

Authors:  Allen F Shih; Alicia J Little; Gauri Panse; Junjie Liu; Gloria Yiu; H Klar Yaggi; Amanda Zubek
Journal:  JAAD Case Rep       Date:  2018-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.